After Regeneron and Sanofi got FDA approval for their cholesterol drug last month, today is Amgen's turn. CNBC's Meg Tirrell reports.
Get the best of CNBC in your inbox
Dan Mangan is a reporter covering health care for CNBC.com.
Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.
Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.